top of page

REMS Bone Scan

Radiation-free insight into bone strength and fracture risk.

A Smarter, Safer Way to Measure Bone Health

REMS uses advanced ultrasound technology to go beyond traditional bone scans, helping detect early bone loss, assess fracture risk, and support proactive, personalized bone health decisions.

ybbb.png

What REMS Measures

Bone Density

Measures Bone Mineral Density (BMD) to assess overall bone strength and detect osteopenia or osteoporosis.

Fracture Risk Prediction

Estimates the likelihood of future fractures by analyzing bone density and quality together for a more accurate risk profile.

Bone Quality (Fragility)

Evaluates the internal structure of bone to determine how resilient it is—not just how dense it appears.

Body Composition

Analyzes fat mass and lean mass distribution to support a more complete understanding of musculoskeletal health.

How REMS Works

01

The device emits sound waves into the bone

02

The sound waves reflect back and are captured by the device

03

Advanced technology analyzes the signals to assess bone density and architecture

REMS vs DXA

Key Benefits & Features
REMS Bone Scan
DXA Scan
Shows bone density & T-Score
Highly accurate measurement
Radiation-free
Detects changes in ≥ 6 months
Includes comprehensive fracture-risk score
Consistent results across machines & technicians
Not affected by arthritis, spinal issues, or implants
Easy-to-read color-coded results
No doctor referral needed
Safe for regular progress tracking
Ideal for early prevention & monitoring

up to 90% of DXA scans are inaccurate due to patient positioning, body composition, & technical errors.

REMS achieves 30% more accuracy than DXA in predicting fracture risk by assessing bone quality & density.

REMS offers 40% greater sensitivity in detecting bone quality changes, improving treatment monitoring.

Echolight REMS Technology
04:50
Differences between R.E.M.S. Technology and DXA
01:02
Why REMS is SUPERIOR to DEXA for Osteoporosis and Why it May Change Your Life!
19:15
NEW OSTEOPOROSIS TECHNOLOGY: Understanding Your REMS Report for Future Stronger Bones
45:23

Insights From Leading Experts

ChatGPT Image Jan 22, 2026, 04_09_49 PM.png

Evidence-Based Insights

Key Finding: Introduced a novel REMS-based method for femoral neck densitometry, offering a non-ionizing alternative to DXA.

An Advanced Quantitative Echosound Methodology for Femoral Neck Densitometry

Ultrasound in Medicine & Biology, 2016

Key Finding: REMS can overcome common DXA artifacts, providing more accurate BMD evaluations.

DXA Beyond Bone Mineral Density and the REMS Technique: New Insights for Current Radiologists Practice

La Radiologia Medica, 2024

Key Finding: Consensus established REMS as a promising technology for assessing bone strength and fracture risk non-invasively.

Radiofrequency Echographic Multi-Spectrometry for the In-vivo Assessment of Bone Strength: State of the Art-Outcomes of an Expert Consensus Meeting Organized by ESCEO

Aging Clinical and Experimental Research, 2019

Key Finding: Confirmed REMS' accuracy and reproducibility for osteoporosis diagnosis in a broad European clinical setting.

Radiofrequency Echographic Multi Spectrometry (REMS) for the diagnosis of osteoporosis in a European multicenter clinical context

Bone, 2021

Key Finding: REMS provided accurate osteoporosis diagnosis in three cases where DXA results were artifactually elevated.

Could Radiofrequency Echographic Multi-Spectrometry (REMS) Overcome the Limitations of BMD by DXA Related to Artifacts? A Series of 3 Cases

Journal of Ultrasound in Medicine, 2021

Key Finding: REMS demonstrates high diagnostic accuracy and precision in evaluating bone health in men, offering a reliable DXA alternative.

Bone Health Status Evaluation in Men by Means of REMS Technology

Aging Clinical and Experimental Research, 2024

Key Finding: REMS was shown to have comparable diagnostic performance to DXA, with advantages in artifact-prone regions.

Radiofrequency Echographic Multi-Spectrometry Compared with Dual X-ray Absorptiometry for Osteoporosis Diagnosis on Lumbar Spine and Femoral Neck

Osteoporosis International, 2019

Key Finding: REMS successfully detected bone changes in breast cancer patients on denosumab and aromatase inhibitors.

Short-term monitoring of denosumab effect in breast cancer patients receiving Aromatase Inhibitors using REMS technology on lumbar spine

Annals of the Rheumatic Diseases, 2020

Key Finding: REMS improves osteoporosis diagnosis accuracy when lumbar spine BMD is artifactually high due to vertebral fractures or osteoarthritis.

Could Radiofrequency Echographic Multi-Spectrometry (REMS) Overcome the Overestimation in BMD by Dual-Energy X-ray Absorptiometry (DXA) at the Lumbar Spine?

BMC Musculoskeletal Disorders, 2022

Key Finding: The REMS-based Fragility Score successfully predicted fragility fractures at 5 years, enhancing fracture risk assessments.

Fragility Score: a REMS-Based Indicator for the Prediction of Incident Fragility Fractures at 5 Years

Aging Clinical and Experimental Research, 2023

Key Finding: REMS predicted fragility fractures over a 5-year period as accurately as or better than traditional DXA.

Radiofrequency Echographic Multi-Spectrometry for the Prediction of Incident Fragility Fractures: A 5-Year Follow-Up Study

Bone, 2020

Key Finding: 92% of DXA reports had errors; 65% impacted diagnosis or treatment. Reporting templates reduced these errors.

DXA Errors Are Common and Reduced by Use of a Reporting Template

Journal of Clinical Densitometry, 2018

Frequently Asked Questions

bottom of page